MEDDEV 2.7-3 : REV 3 : 2015
Current
The latest, up-to-date edition.
CLINICAL INVESTIGATIONS: SERIOUS ADVERSE REPORTING UNDER DIRECTIVES 90/385/EEC AND 93/42/EC
Hardcopy
English
01-05-2015
Important note : Users cannot be edited or removed once added to your Multi user PDF.
1. INTRODUCTION
2. SCOPE
3. DEFINITIONS
4. REPORTABLE EVENTS
5. REPORT BY WHOM
6. REPORT TO WHOM
7. REPORTING TIMELINES
8. CAUSALITY ASSESSMENT
9. REPORTING FORM
Appendix - Summary Reporting Form
The reporting modalities and format set out in this guidance apply to pre-market 2 clinical investigations 3-4 conducted with: a. Non-CE marked devices, b. CE marked devices used outside the intended use(s) covered by the CE- marking.
| DevelopmentNote |
Available for free download. (01/2017)
|
| DocumentType |
Standard
|
| Pages |
12
|
| PublisherName |
European Union
|
| Status |
Current
|
| MEDDEV 2.7-2 : REV 2 | GUIDELINES FOR COMPETENT AUTHORITIES FOR MAKING A VALIDATION/ASSESSMENT OF A CLINICAL INVESTIGATION APPLICATION UNDER DIRECTIVES 90/385/EEC AND 93/42/EC |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.